Magnesium and vascular changes in hypertension

International Journal of Hypertension

Volumn 2012, Issue , 2012, Pages

  Cunha, Ana Rosa ^a   Umbelino, Bianca ^a   Correia, Margarida L ^a   Neves, Mario Fritsch ^a  

^a HOSPITAL UNIVERSITÁRIO PEDRO ERNESTO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

MAGNESIUM; MAGNESIUM OXIDE; PLACEBO; PYROGLUTAMATE MAGNESIUM;

ARTERIAL STIFFNESS; BLOOD PRESSURE MEASUREMENT; CELL LEVEL; DISEASE ASSOCIATION; ENDOTHELIAL DYSFUNCTION; HUMAN; HYPERTENSION; MINERAL INTAKE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME;

EID: 84864189694     PISSN: 20900384     EISSN: 20900392     Source Type: Journal    
DOI: 10.1155/2012/754250     Document Type: Review

References (49)

1. Egan B. M., Zhao Y., Axon R. N., US trends in prevalence, awareness, treatment, and control of hypertension, 19882008. Journal of the American Medical Association 2010 303 20 2043 2050 2-s2.0-77952750659 10.1001/jama.2010.650
2. He K., Liu K., Daviglus M. L., Morris S. J., Loria C. M., van Horn L., Jacobs D. R., Savage P. J., Magnesium intake and incidence of metabolic syndrome among young adults. Circulation 2006 113 13 1675 1682 2-s2.0-33645783203 10.1161/CIRCULATIONAHA.105.588327
3. Hatzistavri L. S., Sarafidis P. A., Georgianos P. I., Tziolas I. M., Aroditis C. P., Zebekakis P. E., Pikilidou M. I., Lasaridis A. N., Oral magnesium supplementation reduces ambulatory blood pressure in patients with mild hypertension. American Journal of Hypertension 2009 22 10 1070 1075 2-s2.0-70349454054 10.1038/ajh.2009.126
4. Bo S., Pisu E., Role of dietary magnesium in cardiovascular disease prevention, insulin sensitivity and diabetes. Current Opinion in Lipidology 2008 19 1 50 56 2-s2.0-38149006370 10.1097/MOL.0b013e3282f33ccc
5. Uza G., Pavel O., Uza D., Valaicu R., Hypomagnesemia in patients with essential arterial hypertension. Magnesium-Bulletin 1987 9 177 180
6. + in platelets and erythrocytes of essential hypertension patients: relation to blood pressure. Clinical and Experimental Hypertension A 1992 14 6 1189 1209
7. Chacko S. A., Song Y., Nathan L., Tinker L., de Boer I. H., Tylavsky F., Wallace R., Liu S., Relations of dietary magnesium intake to biomarkers of inflammation and endothelial dysfunction in an ethnically diverse cohort of postmenopausal women. Diabetes Care 2010 33 2 304 310 2-s2.0-75149151533 10.2337/dc09-1402
8. Barbagallo M., Dominguez L. J., Galioto A., Pineo A., Belvedere M., Oral magnesium supplementation improves vascular function in elderly diabetic patients. Magnesium Research 2010 23 3 131 137 2-s2.0-78149239022
9. Barbagallo M., Dominguez L. J., Galioto A., Ferlisi A., Cani C., Malfa L., Pineo A., Busardo' A., Paolisso G., Role of magnesium in insulin action, diabetes and cardio-metabolic syndrome X. Molecular Aspects of Medicine 2003 24 13 39 52 2-s2.0-0037421518 10.1016/S0098-2997(02)00090-0 (Pubitemid 36092143)
10. K. Griendling K., E. Rittenhouse S., A. Brock T., S. Ekstein L., A. Gimbrone Jr. M., W. Alexander R., Sustained diacylglycerol formation from inositol phospholipids in angiotensin II-stimulated vascular smooth muscle cells. The Journal of Biological Chemistry 1986 261 13 5901 5906 (Pubitemid 17207422)
11. Sontia B., Touyz R. M., Role of magnesium in hypertension. Archives of Biochemistry and Biophysics 2007 458 1 33 39 2-s2.0-33846647038 10.1016/j.abb.2006.05.005 (Pubitemid 46186225)
12. Mazur A., Maier J. A. M., Rock E., Gueux E., Nowacki W., Rayssiguier Y., Magnesium and the inflammatory response: potential physiopathological implications. Archives of Biochemistry and Biophysics 2007 458 1 48 56 2-s2.0-33846815090 10.1016/j.abb.2006.03.031 (Pubitemid 46201802)
13. Barbagallo M., Dominguez L. J., Magnesium metabolism in type 2 diabetes mellitus, metabolic syndrome and insulin resistance. Archives of Biochemistry and Biophysics 2007 458 1 40 47 2-s2.0-33846593912 10.1016/j.abb.2006.05.007 (Pubitemid 46186226)
14. Paolisso G., Sgambato S., Passariello N., Insulin induces opposite changes in plasma and erythrocyte magnesium concentrations in normal man. Diabetologia 1986 29 9 644 647 2-s2.0-0022470384 (Pubitemid 16031791)
15. Schnack C., Bauer I., Pregant P., Hopmeier P., Schernthaner G., Hypomagnesaemia in Type 2 (non-insulin-dependent) diabetes mellitus is not corrected by improvement of long-term metabolic control. Diabetologia 1992 35 1 77 79 2-s2.0-0026601697
16. G. Kolterman O., S. Gray R., Griffin J., Receptor and postreceptor defects contribute to the insulin resistance in noninsulin-dependent diabetes mellitus. The Journal of Clinical Investigation 1981 68 4 957 969 (Pubitemid 11023523)
17. Durlach J., Durlach V., Speculations on hormonal controls of magnesium homeostasis: a hypothesis. Magnesium 1984 3 3 109 131 2-s2.0-0021660606
18. Hadjistavri L. S., Sarafidis P. A., Georgianos P. I., Tziolas I. M., Aroditis C. P., Hitoglou-Makedou A., Zebekakis P. E., Pikilidou M. I., Lasaridis A. N., Beneficial effects of oral magnesium supplementation on insulin sensitivity and serum lipid profile. Medical Science Monitor 2010 16 6 CR307 CR312 2-s2.0-77955335262
19. Sanjuliani A. F., de Abreu Fagundes V. G., Francischetti E. A., Effects of magnesium on blood pressure and intracellular ion levels of Brazilian hypertensive patients. International Journal of Cardiology 1996 56 2 177 183 2-s2.0-0030271350 10.1016/S0167-5273(96)02716-7 (Pubitemid 26317280)
20. F. Júnior R., J. D. da Silva V., C. Salgado H., Modelos de Hipertensão Arterial. Revista Brasileira de Hipertensão 2001 8 19 29
21. Touyz R. M., Milne F. J., Magnesium supplementation attenuates, but does not prevent, development of hypertension in spontaneously hypertensive rats. American Journal of Hypertension 1999 12 8, part 1 757 765 2-s2.0-0032849981 10.1016/S0895-7061(99)00064-3 (Pubitemid 29416839)
22. Chobanian A. V., Bakris G. L., Black H. R., Cushman W. C., Green L. A., Izzo J. L., Jones D. W., Materson B. J., Oparil S., Wright J. T., Roccella E. J., Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003 42 6 1206 1252 2-s2.0-0347423198 10.1161/01.HYP.0000107251.49515.c2 (Pubitemid 37553153)
23. Mancia G., de Backer G., Dominiczak A., Cifkova R., Fagard R., Germano G., Grassi G., Heagerty A. M., Kjeldsen S. E., Laurent S., Narkiewicz K., Ruilope L., Rynkiewicz A., Schmieder R. E., Struijker Boudier H. A. J., Zanchetti A., ESH/ESC 2007 guidelines for the management of arterial hypertension. Revista Espanola de Cardiologia 2007 60 9 968.e1 968.e94 2-s2.0-35748974873 10.1157/13109650
24. Touyz R. M., Pu Q., He G., Chen X., Yao G., Neves M. F., Viel E., Effects of low dietary magnesium intake on development of hypertension in stroke-prone spontaneously hypertensive rats: role of reactive oxygen species. Journal of Hypertension 2002 20 11 2221 2232 2-s2.0-0036854603 10.1097/00004872-200211000- 00022 (Pubitemid 35388241)
25. Resnick L. M., Laragh J. H., Sealey J. E., Alderman M. H., Divalent cations in essential hypertension: relations between serum ionized calcium, magnesium, and plasma renin activity. The New England Journal of Medicine 1983 309 15 888 891 2-s2.0-0020511061 (Pubitemid 13014029)
26. Kawano Y., Role of blood pressure monitoring in non-pharmacological management of hypertension. Blood Pressure Monitoring 2002 7 1 51 54 2-s2.0-0035992037 10.1097/00126097-200202000-00010 (Pubitemid 34304053)
27. Khan A. M., Sullivan L., McCabe E., Levy D., Vasan R. S., Wang T. J., Lack of association between serum magnesium and the risks of hypertension and cardiovascular disease. American Heart Journal 2010 160 4 715 720 2-s2.0-77957837414 10.1016/j.ahj.2010.06.036
28. Wu G., Tian H., Han K., Xi Y., Yao Y., Ma A., Potassium magnesium supplementation for four weeks improves small distal artery compliance and reduces blood pressure in patients with essential hypertension. Clinical and Experimental Hypertension 2006 28 5 489 497 2-s2.0-33745844830 10.1080/10641960600798705 (Pubitemid 44034673)
29. Kawano Y., Matsuoka H., Takishita S., Omae T., Effects of magnesium supplementation in hypertensive patients: assessment by office, home, and ambulatory blood pressures. Hypertension 1998 32 2 260 265 2-s2.0-0031843971 (Pubitemid 28376482)
30. Yamamoto M. E., Applegate W. B., Klag M. J., Borhani N. O., Cohen J. D., Kirchner K. A., Lakatos E., Sacks F. M., Taylor J. O., Hennekens C. H., Lack of blood pressure effect with calcium and magnesium supplementation in adults with high-normal blood pressure: results from phase I of the Trials of Hypertension Prevention (TOHP). Annals of Epidemiology 1995 5 2 96 107 10.1016/1047-2797(94) 00054-W
31. Ferrara L. A., Iannuzzi R., Castaldo A., Iannuzzi A., Dello Russo A., Mancini M., Long-term magnesium supplementation in essential hypertension. Cardiology 1992 81 1 25 33 2-s2.0-0026496463
32. Lind L., Lithell H., Pollare T., Ljunghall S., Blood pressure response during long-term treatment with magnesium is dependent on magnesium status. A double-blind, placebo-controlled study in essential hypertension and in subjects with high-normal blood pressure. American Journal of Hypertension 1991 4 8 674 679 2-s2.0-0025861083
33. Laurent S., Boutouyrie P., Asmar R., Gautier I., Laloux B., Guize L., Ducimetiere P., Benetos A., Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001 37 5 1236 1241 2-s2.0-0035714567 (Pubitemid 34163575)
34. Benetos A., Adamopoulos C., Bureau J. M., Temmar M., Labat C., Bean K., Thomas F., Pannier B., Asmar R., Zureik M., Safar M., Guize L., Determinants of accelerated progression of arterial stiffness in normotensive subjects and in treated hypertensive subjects over a 6-year period. Circulation 2002 105 10 1202 1207 2-s2.0-0037066012 10.1161/hc1002.105135 (Pubitemid 34225821)
35. Adji A., O'Rourke M. F., Namasivayam M., Arterial stiffness, its assessment, prognostic value, and implications for treatment. American Journal of Hypertension 2011 24 1 5 17 2-s2.0-78650294746 10.1038/ajh.2010.192
36. van Laecke S., steven.vanlaecke@ugent.be Maréchal C., Verbeke F., Peeters P., van Biesen W., Devuyst O., Jadoul M., Vanholder R., The relation between hypomagnesaemia and vascular stiffness in renal transplant recipients. Nephrology Dialysis Transplantation 2011 26 7 2362 2369 10.1093/ndt/gfq728
37. Laurant P., Hayoz D., Brunner H., Berthelot A., Dietary magnesium intake can affect mechanical properties of rat carotid artery. British Journal of Nutrition 2000 84 5 757 764 2-s2.0-0033661338
38. Touyz R. M., Schiffrin E. L., Reactive oxygen species in vascular biology: implications in hypertension. Histochemistry and Cell Biology 2004 122 4 339 352 2-s2.0-8644277006 10.1007/s00418-004-0696-7 (Pubitemid 39506592)
39. Laurant P., Touyz R. M., Physiological and pathophysiological role of magnesium in the cardiovascular system: implications in hypertension. Journal of Hypertension 2000 18 9 1177 1191 2-s2.0-0033821519
40. 2+]e enhances arterial spontaneous tone via phosphatidylinositol 3-kinase in DOCA-salt hypertension. Hypertension 2004 43 1 125 129
41. Laurant P., Berthelot A., Endothelin-1-induced contraction in isolated aortae from normotensive and DOCA-salt hypertensive rats: effect of magnesium. British Journal of Pharmacology 1996 119 7 1367 1374 2-s2.0-0029850341 (Pubitemid 26402014)
42. Shechter M., Sharir M., Labrador M. J., James L., Burton F., Noel S. C., Merz B., Oral magnesium therapy improves endothelial function in patients with coronary artery disease. Circulation 2000 102 19 2353 2358
43. Almoznino-Sarafian D., Sarafian G., Berman S., Shteinshnaider M., Tzur I., Cohen N., Gorelik O., Magnesium administration may improve heart rate variability in patients with heart failure. Nutrition, Metabolism and Cardiovascular Diseases 2009 19 9 641 645 2-s2.0-70350567766 10.1016/j.numecd.2008.12.002
44. Guerrero-Romero F., Rodríguez-Morán M., The effect of lowering blood pressure by magnesium supplementation in diabetic hypertensive adults with low serum magnesium levels: a randomized, double-blind, placebo-controlled clinical trial. Journal of Human Hypertension 2009 23 4 245 251 2-s2.0-63349092570 10.1038/jhh.2008.129
45. Guerrero-Romero F., guerrero-romero@hotmail.com Tamez-Perez H. E., González-González G., Salinas-Martínez A. M., Montes-Villarreal J., Treviño-Ortiz J. H., Rodríguez-Morán M., Oral Magnesium supplementation improves insulin sensitivity in non-diabetic subjects with insulin resistance: a double-blind placebo-controlled randomized trial. Diabetes and Metabolism 2004 30 3 253 258 (Pubitemid 38917455)
46. Lee S., Park H. K., Son S. P., Lee C. W., Kim I. J., Kim H. J., Effects of oral magnesium supplementation on insulin sensitivity and blood pressure in normo-magnesemic nondiabetic overweight Korean adults. Nutrition, Metabolism and Cardiovascular Diseases 2009 19 11 781 788 2-s2.0-70449704177 10.1016/j.numecd.2009.01.002
47. Touyz R. M., Role of magnesium in the pathogenesis of hypertension. Molecular Aspects of Medicine 2003 24 13 107 136 2-s2.0-0037421538 10.1016/S0098-2997(02)00094-8 (Pubitemid 36096860)
48. Haenni A., Johansson K., Lind L., Lithell H., Magnesium infusion improves endothelium-dependent vasodilation in the human forearm. American Journal of Hypertension 2002 15 1, part 1 10 15 2-s2.0-0036152788 10.1016/S0895-7061(01) 02225-7 (Pubitemid 34102266)
49. Dickinson H.O. Nicolson D.J. Campbell F. Cook J.V. Beyer F.R. Ford G.A. Mason J. Magnesium supplementation for the management of essential hypertension in adults, Cochrane Database of Systematic Reviews 2006 3 CD004640 2-s2.0-33750122862